Literature DB >> 33268482

Redistribution of Monocyte Subsets in Obstructive Sleep Apnea Syndrome Patients Leads to an Imbalanced PD-1/PD-L1 Cross-Talk with CD4/CD8 T Cells.

Christina Polasky1, Armin Steffen1, Kristin Loyal1, Christian Lange1, Karl-Ludwig Bruchhage1, Ralph Pries2.   

Abstract

Obstructive sleep apnea syndrome (OSAS) represents a substantial disease of recurrent sleep fragmentation, leading to intermittent hypoxia and subsequent diseases such as cardiovascular, metabolic, or cognitive dysfunctions. In addition, OSAS is considered as low-grade systemic inflammation, which is associated with a higher incidence of cancer, severity of infections, and an overall immune dysregulation. This research project aims to comprehensively investigate the interplay of wholesome sleep and the immune functions of circulating monocytes and T cells in OSAS patients, which are known to be affected by oxidative stress. We studied the distribution of the CD14/CD16 characterized monocyte subsets in peripheral blood as well as their PD-L1 expression and complex formation with T cells. Furthermore, a detailed analysis of T cell subsets with regard to their PD-1 and PD-L1 expression was performed. Data revealed a decrease of classical monocytes accompanied by an increase of both CD16+ monocyte subsets in OSAS patients that was positively correlated with the body mass index. OSAS patients revealed an increased PD-1 and PD-L1 expression in T cells and monocytes, respectively, which was linked to the severity of monocyte subset alterations. The complex formation of monocytes and T cells was also elevated in OSAS patients, which indicates a deregulated PD-1/PD-L1 cross-talk between these cells. Our data show for the first time, to our knowledge, massive alterations of peripheral monocyte subsets in response to OSAS and its accompanying phenomena.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33268482     DOI: 10.4049/jimmunol.2001047

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Cellular Immune Dysfunction in Obstructive Sleep Apnea.

Authors:  Katharina Ludwig; Tilman Huppertz; Markus Radsak; Haralampos Gouveris
Journal:  Front Surg       Date:  2022-07-06

2.  Increased Abundances of CD16+ Non-Classical Monocytes Accompany with Elevated Monocytic PD-L1 and CD4+ T Cell Disturbances in Oropharyngeal Cancer.

Authors:  Christian Idel; Christina Polasky; Julika Ribbat-Idel; Kristin Loyal; Sven Perner; Dirk Rades; Karl-Ludwig Bruchhage; Ralph Pries
Journal:  Biomedicines       Date:  2022-06-09

3.  Smoking-, Alcohol-, and Age-Related Alterations of Blood Monocyte Subsets and Circulating CD4/CD8 T Cells in Head and Neck Cancer.

Authors:  Christian Idel; Kristin Loyal; Dirk Rades; Samer G Hakim; Udo Schumacher; Karl-Ludwig Bruchhage; Ralph Pries
Journal:  Biology (Basel)       Date:  2022-04-25

Review 4.  Clinical outcomes and influencing factors of PD-1/PD-L1 in hepatocellular carcinoma.

Authors:  Jiting Wang; Jun Li; Guiju Tang; Yuan Tian; Song Su; Yaling Li
Journal:  Oncol Lett       Date:  2021-02-10       Impact factor: 2.967

5.  Reconstitution of Monocyte Subsets and PD-L1 Expression but Not T Cell PD-1 Expression in Obstructive Sleep Apnea Patients upon PAP Therapy.

Authors:  Christina Polasky; Armin Steffen; Kristin Loyal; Christian Lange; Karl-Ludwig Bruchhage; Ralph Pries
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

6.  Impact of Superparamagnetic Iron Oxide Nanoparticles on THP-1 Monocytes and Monocyte-Derived Macrophages.

Authors:  Christina Polasky; Tim Studt; Ann-Kathrin Steuer; Kristin Loyal; Kerstin Lüdtke-Buzug; Karl-Ludwig Bruchhage; Ralph Pries
Journal:  Front Mol Biosci       Date:  2022-02-04

7.  Dynamics of Circulating CD14/CD16 Monocyte Subsets in Obstructive Sleep Apnea Syndrome Patients upon Hypoglossal Nerve Stimulation.

Authors:  Ralph Pries; Christian Lange; Nicole Behn; Karl-Ludwig Bruchhage; Armin Steffen
Journal:  Biomedicines       Date:  2022-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.